ENZORAB-LS

ENZORAB–LS Capsules (Rabeprazole Sodium EC & Levosulpiride SR) – Complete Relief from Acidity & Gastric Discomfort

ENZORAB–LS Capsules combine Rabeprazole Sodium (Enteric Coated) and Levosulpiride (Sustained Release) to provide effective and long-lasting relief from acidity, reflux, and digestive discomfort. This dual-action formulation targets both excess acid production and impaired gastric motility for comprehensive gastrointestinal care.

Rabeprazole is a proton pump inhibitor (PPI) that reduces stomach acid secretion, helping relieve heartburn, acid reflux, and gastric irritation. Levosulpiride is a prokinetic agent that improves stomach emptying, reduces bloating, nausea, and fullness, and enhances digestive function.

Key Benefits:

• Provides effective relief from acidity and heartburn

• Reduces acid production and prevents reflux

• Improves gastric motility and digestion

• Relieves bloating, nausea, and upper abdominal discomfort

• Suitable for long-term management of GERD and gastritis

Composition:
Rabeprazole Sodium (Enteric Coated) & Levosulpiride (Sustained Release)

Dosage Form: Capsules
Category: Proton Pump Inhibitor & Prokinetic Combination
Indication: GERD, hyperacidity, gastritis, reflux disorder, and functional dyspepsia (as directed by physician)